ArticleThe western journal of emergency medicine2025
Retention Challenges in Opioid Use Disorder Treatment: The Role of Comorbid Psychological Conditions.
Article in The western journal of emergency medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Retention Challenges in Opioid Use Disorder Treatment: The Role of Comorbid Psychological Conditions.The western journal of emergency medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionComorbid psychological conditions have an impact on opioid use disorder (OUD). We measured multiple psychological tests in OUD patients who entered an emergency department (ED)-based medication for opioid use disorder (MOUD) program to determine whether any test correlated with six-month retention in the MOUD treatment program.
methodsPatients with OUD who were enrolled in an ED-based MOUD program over a 12-month period were eligible to participate. We surveyed enrollees using nine validated tools to assess depression, anxiety, and traumatic stress within 24 hours of their ED presentation and then at one and six months. The primary outcome was program retention rates at one and six months. Secondary outcomes were levels of clinical symptoms, substance use, and quality of life.
resultsOf 143 patients enrolled in the MOUD program, 64 (44.8%) participated during the 12-month study. The mean age was 33 years, with 65% male and 35% female. Baseline surveys indicated moderate symptom severity for depression and anxiety. The Post-Traumatic Stress Disorder Checklist (PCL-5) scores showed significant traumatic stress. Retention rates were 47% at one month and 25% at six months. General well-being improved from 40% at baseline to 56% at six months. Average income correlated (0.51) with six-month retention, suggesting that those with financial means were more likely to remain in treatment. The Life Events Checklist (LEC-5) correlated (0.41) with six-month retention. This indicates that the more trauma an individual experienced, the less likely the person would remain in treatment.
conclusionHigher income and lower post-traumatic stress disorder scores had higher retention rates in a medication-based opioid use disorder program. Psychological surveys of patients entering a MOUD program may help predict treatment retention. There will likely be challenges in keeping patients with extensive trauma histories retained in treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.